InsidersTradesSigma
Browse the detailed record of transactions filed by Maynard Ryan D, 董事. Director active across 1 company, notably Iovance Biotherapeutics, INC.. Aggregated, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €47k. Activity tracked since 31 May 2022. The latest transaction was disclosed on 31 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Ryan D. Maynard is a Director of IOVANCE BIOTHERAPEUTICS, INC. As a board member, he contributes to the governance and strategy of the company. His experience in the biopharmaceutical sector is valuable for IOVANCE.